Investing.com - Varian reported on Tuesday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Varian announced earnings per share of $1.12 on revenue of $850.5M. Analysts polled by Investing.com anticipated EPS of $1.01 on revenue of $823.24M.
Varian shares are up 21% from the beginning of the year, still down 1.80% from its 52 week high of $176.13 set on August 4. They are outperforming the S&P 500 which is up 4.95% from the start of the year.
Varian follows other major Healthcare sector earnings this month
Varian's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on Tuesday with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.69 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar